– Adults with symptomatology compatible with colorectal cancer.
– Adults at screening age (≥50 years).
– Adults with no symptoms with interest in undergoing a control for early detection of colorectal cancer.
GoodGut has developed RAID-CRC, a non-invasive test that complements the fecal occult blood test, significantly reducing unnecessary colonoscopies and detecting CRC precisely and in early stages without discomfort for patients. This tool is possible thanks to more than 20 years of top-level research of the GoodGut’s team, devoted to research intestinal microbiota as agents indicative of CRC.
Request the online visit to know the results of your analysis from home.
RAID-CRC determines a specific bacterial signature associated with CRC together with the analysis of fecal occult blood. The test has been optimized and validated in several clinical studies in reference hospitals, corroborating that the test presents a sensitivity of 98% and specificity of 92% for CRC, allowing to reduce up to 30% of unnecessary colonoscopies*.
RAID-CRC and FIT are analyzed in GoodGut’s Laboratory as a service under a quality system certified by the ISO13485:2016, required for medical devices.
*Malagón et al. 2019, 2020.
Take a fecal sample following the instructions of the kit. There is a free pick up of the sample at home in 24 h.
Within 5 working days from the reception of the sample in the laboratory, the specialist will receive the diagnostic report of CRC together with the quantitative value of FIT. Then, you will be notified by email that your specialist has received the results.
Schedule an online or face-to-face visit with a professional expert to receive assessment and, if needed, immediate treatment.
RAID-CRC is a non-invasive test
For subjects over 18 years, with symptomatology compatible with colorectal cancer or adults eligible for screening (over 50 years). It is also for subjects with no symptoms interested in undergoing a routinary control/check-up for early detection of colorectal cancer.
The test cannot be performed in case of pregnancy or during menstruation. In case of having had an oral or parenteral antibiotic, having had a colonoscopy, colon cleansing, or enema, it is necessary to wait at least 30 days.
The election technique for diagnosing colorectal cancer (CRC) is colonoscopy, but it is an invasive and costly technique. Therefore, the screening programs based on the early detection of CRC for its prevention use non-invasive tests, being the most common the fecal immunochemical test (FIT). However, this method yields a high false-positive rate, implying up to 30% of unnecessary colonoscopies.
RAID-CRC determines a specific bacterial signature associated with CRC along with the analysis of the fecal immunochemical test. This test has been optimized and validated in multiple clinical studies in pioneering hospitals, which corroborate that the test presents a 98% sensitivity and 92% specificity for CRC, allowing a reduction of 30% of the unnecessary colonoscopies.
For more information, you can check the Scientific Articles section.